Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 338
Gene Symbol: APOB
APOB
0.100 GeneticVariation disease BEFREE We have examined the frequency of the EcoRI and XbaI RFLPs of the apoB gene in 95 white Type 2 diabetic patients aged between 45 and 80 years in order to ascertain whether variation in this gene may be influencing the development of Type 2 diabetes and associated atherosclerosis through obesity. 1685948 1992
Entrez Id: 7448
Gene Symbol: VTN
VTN
0.030 Biomarker disease BEFREE These results suggest that GP66 is rabbit vitronectin and that it is vitronectin which selectively accumulates in thoracic aorta with the development of atherosclerosis. 1701177 1990
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.100 AlteredExpression disease BEFREE These data identify IL-4 and interferon gamma as physiological regulators of lipoxygenase expression and suggest an important link between 15-lipoxygenase function and the immune/inflammatory response in atherosclerosis as well as other diseases. 1729692 1992
Entrez Id: 3565
Gene Symbol: IL4
IL4
0.080 AlteredExpression disease BEFREE These data identify IL-4 and interferon gamma as physiological regulators of lipoxygenase expression and suggest an important link between 15-lipoxygenase function and the immune/inflammatory response in atherosclerosis as well as other diseases. 1729692 1992
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Thus, the genetic polymorphism of apolipoprotein E may contribute to the individual risk of accelerated atherosclerosis in patients under maintenance hemodialysis. 1733833 1992
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.070 AlteredExpression disease BEFREE Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. 1739124 1992
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.100 Biomarker disease BEFREE The data obtained in this study may indicate an enhanced metabolism of elastin in ATH children. 1789803 1991
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.100 Biomarker disease BEFREE Lipoprotein(a) and atherosclerosis. 1829339 1991
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.300 Biomarker disease BEFREE The molecular genetic defect of a female patient with apolipoprotein A-I (apoA-I) deficiency and premature atherosclerosis was examined.Her parents were first cousins. 1901417 1991
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.100 Biomarker disease BEFREE Lipoprotein (a) concentrations as risk indicators for atherosclerosis. 1929512 1991
Entrez Id: 3240
Gene Symbol: HP
HP
0.100 GeneticVariation disease BEFREE Variation at the haptoglobin locus could have a direct effect on the degradation of elastin in atherosclerotic aorta, whereas variation at the cholesterol ester transfer protein locus could affect lipid metabolism and promote atherosclerosis.(ABSTRACT TRUNCATED AT 250 WORDS) 1967566 1990
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.100 GeneticVariation disease BEFREE Variation at the haptoglobin locus could have a direct effect on the degradation of elastin in atherosclerotic aorta, whereas variation at the cholesterol ester transfer protein locus could affect lipid metabolism and promote atherosclerosis.(ABSTRACT TRUNCATED AT 250 WORDS) 1967566 1990
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.300 Biomarker disease BEFREE In conclusion, (1) the presence of NIDDM in the proband appears to be associated in siblings with more profound lipid and lipoprotein changes (especially low HDL cholesterol and high total triglycerides) than a history of CHD in the proband, (2) a history of CHD in the proband is associated in children with apolipoprotein changes favouring atherosclerosis (low apolipoprotein A1, high apolipoprotein B, low apolipoprotein A1/B ratio). 2064632 1991
Entrez Id: 55349
Gene Symbol: CHDH
CHDH
0.090 GeneticVariation disease BEFREE The authors concluded that the most important methods of prevention of atherosclerosis in youth should be: identification of high-risk individuals (overweight, hypertension, hyperlipidemia, family history of CHD and PAD, ischemic postexercise ST segment depression), health education and motivation for change, modification nutritional habits in cases of hyperlipidemia and overweight (prevention of early atherosclerotic lesions in childhood), early diagnosis and control of hypertension, practice of low salt intake, avoidance of smoking, sufficient physical activity (prevention of atherosclerotic disease mainly in adulthood). 2212795 1990
Entrez Id: 23569
Gene Symbol: PADI4
PADI4
0.080 Biomarker disease BEFREE The authors concluded that the most important methods of prevention of atherosclerosis in youth should be: identification of high-risk individuals (overweight, hypertension, hyperlipidemia, family history of CHD and PAD, ischemic postexercise ST segment depression), health education and motivation for change, modification nutritional habits in cases of hyperlipidemia and overweight (prevention of early atherosclerotic lesions in childhood), early diagnosis and control of hypertension, practice of low salt intake, avoidance of smoking, sufficient physical activity (prevention of atherosclerotic disease mainly in adulthood). 2212795 1990
Entrez Id: 79665
Gene Symbol: DHX40
DHX40
0.050 Biomarker disease BEFREE The authors concluded that the most important methods of prevention of atherosclerosis in youth should be: identification of high-risk individuals (overweight, hypertension, hyperlipidemia, family history of CHD and PAD, ischemic postexercise ST segment depression), health education and motivation for change, modification nutritional habits in cases of hyperlipidemia and overweight (prevention of early atherosclerotic lesions in childhood), early diagnosis and control of hypertension, practice of low salt intake, avoidance of smoking, sufficient physical activity (prevention of atherosclerotic disease mainly in adulthood). 2212795 1990
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.300 GeneticVariation disease BEFREE Restriction-fragment-length polymorphisms flanking the insulin and apolipoprotein A-I and C-III genes, although not associated with gestational diabetes mellitus, may be associated with hyperlipidemia and subsequent atherosclerosis. 2261842 1990
Entrez Id: 338
Gene Symbol: APOB
APOB
0.100 GeneticVariation disease BEFREE Several recent reports have examined whether there is a correlation between the presence of some minor alleles of the highly polymorphic apolipoprotein B gene and atherosclerosis and premature heart disease. 2351870 1990
Entrez Id: 5155
Gene Symbol: PDGFB
PDGFB
0.010 AlteredExpression disease BEFREE Since human arterial SMC in culture express receptors for and are mitogenically responsive to platelet-derived growth factor, transcription of the sis gene by cells within lesions, whether these cells are SMC themselves, macrophages, endothelial cells, or another cell type, suggests that an autocrine and/or paracrine proliferative mechanism is important in the pathogenesis of atherosclerosis. 2434949 1987
Entrez Id: 3949
Gene Symbol: LDLR
LDLR
0.100 GeneticVariation disease BEFREE Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. 2524837 1989
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.100 GeneticVariation disease BEFREE Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. 2524837 1989
Entrez Id: 875
Gene Symbol: CBS
CBS
0.040 Biomarker disease BEFREE Arteriosclerosis seems to be increased in heterozygotes as well (cystathionine beta-synthase gene dosage 50%) but rare in Down syndrome (cystathionine beta-synthase gene dosage 150%). 2533642 1989
Entrez Id: 102724560
Gene Symbol: CBSL
CBSL
0.040 Biomarker disease BEFREE Arteriosclerosis seems to be increased in heterozygotes as well (cystathionine beta-synthase gene dosage 50%) but rare in Down syndrome (cystathionine beta-synthase gene dosage 150%). 2533642 1989
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.300 GeneticVariation disease BEFREE In summary, by showing that Lp(a) concentrations and apo(a) apparent size are highly correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene, we provide a DNA marker for this atherosclerosis risk factor as well as an important insight into the genetic mechanism regulating Lp(a) levels. 2556454 1989
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.100 GeneticVariation disease BEFREE In summary, by showing that Lp(a) concentrations and apo(a) apparent size are highly correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene, we provide a DNA marker for this atherosclerosis risk factor as well as an important insight into the genetic mechanism regulating Lp(a) levels. 2556454 1989